http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-388193-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-12 |
| filingDate | 1971-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1973-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-388193-A1 |
| titleOfInvention | PROCEDURE FOR THE PREPARATION OF 5-AZAPYRIMIDIN-NUCLEO-SIDOS. |
| abstract | 5-Azapyrimidine nucleosides of the formula WHEREIN X is NH or an oxygen atom and Z is a free or blocked sugar residue having cytotoxic, antiviral, enzyme-inhibiting, immunosuppressive, anti-inflammatory and antipsoriatic activity are prepared by the reaction in the presence of a Lewis acid, of a 1-O-acyl-, 1-O-alkyl- or 1-holoderivative of a blocked sugar with a compound of the general formula wherein D is a silylated or alkylated O-group and E is a silylated or alkylated O- or NH-group, the blocking groups of the sugar residue thereafter optionally being split off in a conventional manner to produce the corresponding free nucleoside. |
| priorityDate | 1970-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688 |
Total number of triples: 12.